Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. (2021)

First Author: Le Vu S
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-23233-6

PubMed Identifier: 34021152

Publication URI: http://europepmc.org/abstract/MED/34021152

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723